Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia

Clinical trial NCT00358046 · UNKNOWN

Trial details

NCT number: NCT00358046
Sponsor: Ilypsa
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Diseases Renal Insufficiency

Start date: 2006-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.